Latest FDA User Fee Bill Unlikely To Include Major Reforms

Law360, New York (March 25, 2013, 7:51 PM EDT) -- This year's U.S. Food and Drug Administration animal-drug user fee reauthorization won't come nearly as loaded with FDA reforms as past user fee bills, experts say, warning the legislation is unlikely to build the necessary political momentum to push through the more controversial measures that drugmakers and public health groups would like to see.

The animal-drug user fee bill, S. 622, was approved by the Senate Health, Education, Labor and Pensions Committee in a voice vote Wednesday. The bill only reauthorizes the fees for brand-name and...
To view the full article, register now.